Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells

Kidney International

Volumn 56, Issue 2, 1999, Pages 471-478

  Yura, Takafumi ^a,b   Fukunaga, Megumu ^a,c   Khan, Rizwan ^a   Nassar, George N ^a   Badr, Kamal F ^a   Montero, Angel ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d NONE   (United States)

Author keywords

Endothelial cell; Isoprostanes; Lipid peroxidation; Oxidant injury; Prostanoids; Vasoconstrictor

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; ANTIBODY; ENDOTHELIN 1; FREE RADICAL; INOSITOL 1,4,5 TRISPHOSPHATE; ISOPROSTANE; PROTEIN; THROMBOXANE A2 RECEPTOR;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; BINDING SITE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; GENE EXPRESSION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

EID: 0032807290     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00596.x     Document Type: Article

References (16)

1. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387, 1992
2. 2-isoprostanes) in smokers: Smoking as a cause of oxidative damage. N Engl J Med 332:1198-1203, 1995
3. 3. HAAK T, JUNGMANN E, RAAB C, USADEL KH: Elevated endothelin-1 levels after cigarette smoking. Metabolism 43:267-269, 1994
4. 2-isoprostanes) in the hepatorenal syndrome. J Lipid Med 6:417-420, 1993
5. 5. MOORE K, WENDON J, FRAZER M, KARANI J, WILLIAMS R, BADR KF: Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327:1774-1778, 1992
6. 2 receptors. J Clin Invest 90:136-141, 1992
7. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 264:C1619-C1624, 1993
8. 2. Am J Physiol 272:F477-F483, 1997
9. 9. MYERS PR, GUERRA R JR, HARRISON DG: Release of NO and EDRF from cultured bovine aortic endothelial cells. Am J Physiol 256:H1030-H1037, 1989
10. 10. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-PhOH-chloroform extraction. Anal Biochem 162:156-159, 1987
11. 11. McPHERSON GA: Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC. J Pharmacol Methods 14:213-228, 1985
12. 2 in vascular smooth muscle cells. Biochem Pharmacol 40:2535-2542, 1990
13. 13. BERRIDGE MJ, IRVINE RF: Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312:315-321, 1984
14. 14. OGLETREE ML, HARRIS DN, GREENBERG R, HASLANGER MF, NAKANE M: Pharmacological actions of SQ29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234:435-441, 1985
15. 15. EMORI T, HIRATA Y, OHTA K, SHICHIRI M, MARUMO F: Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 160:93-100, 1989
16. 16. SCHELLING JR, LINAS SL: Hepatorenal syndrome. Semin Nephrol 10:565-570, 1990